Cohort (CHRT) Competitors GBX 1,332 +14.00 (+1.06%) As of 12:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock CHRT vs. CHG, BOE, GEC, SNR, AVON, HARL, VEL, AERO, RR, and BAShould you be buying Cohort stock or one of its competitors? The main competitors of Cohort include Chemring Group (CHG), Boeing (BOE), General Electric (GEC), Senior (SNR), Avon Protection (AVON), Harland & Wolff Group (HARL), Velocity Composites (VEL), Strat Aero (AERO), Rolls-Royce Holdings plc (RR), and BAE Systems (BA). These companies are all part of the "aerospace & defense" industry. Cohort vs. Its Competitors Chemring Group Boeing General Electric Senior Avon Protection Harland & Wolff Group Velocity Composites Strat Aero Rolls-Royce Holdings plc BAE Systems Chemring Group (LON:CHG) and Cohort (LON:CHRT) are both small-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has better earnings and valuation, CHG or CHRT? Cohort has lower revenue, but higher earnings than Chemring Group. Cohort is trading at a lower price-to-earnings ratio than Chemring Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemring Group£521.30M2.92£2.18M£0.163,575.95Cohort£270.04M2.25£17.19M£0.443,010.17 Do analysts rate CHG or CHRT? Chemring Group presently has a consensus target price of GBX 570, indicating a potential upside of 0.88%. Cohort has a consensus target price of GBX 1,630, indicating a potential upside of 22.37%. Given Cohort's higher possible upside, analysts clearly believe Cohort is more favorable than Chemring Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemring Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Cohort 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CHG or CHRT more profitable? Cohort has a net margin of 7.56% compared to Chemring Group's net margin of 0.64%. Cohort's return on equity of 14.91% beat Chemring Group's return on equity.Company Net Margins Return on Equity Return on Assets Chemring Group0.64% 0.88% 7.03% Cohort 7.56%14.91%5.54% Do insiders and institutionals have more ownership in CHG or CHRT? 68.8% of Chemring Group shares are owned by institutional investors. Comparatively, 46.0% of Cohort shares are owned by institutional investors. 1.2% of Chemring Group shares are owned by company insiders. Comparatively, 28.4% of Cohort shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor CHG or CHRT? In the previous week, Cohort had 4 more articles in the media than Chemring Group. MarketBeat recorded 6 mentions for Cohort and 2 mentions for Chemring Group. Cohort's average media sentiment score of 1.01 beat Chemring Group's score of 0.75 indicating that Cohort is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemring Group 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cohort 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CHG or CHRT? Chemring Group has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Cohort has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Is CHG or CHRT a better dividend stock? Chemring Group pays an annual dividend of GBX 0.08 per share and has a dividend yield of 0.0%. Cohort pays an annual dividend of GBX 0.15 per share and has a dividend yield of 0.0%. Chemring Group pays out 49.4% of its earnings in the form of a dividend. Cohort pays out 34.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SummaryCohort beats Chemring Group on 9 of the 17 factors compared between the two stocks. Get Cohort News Delivered to You Automatically Sign up to receive the latest news and ratings for CHRT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHRT vs. The Competition Export to ExcelMetricCohortAerospace & Defense IndustryIndustrials SectorLON ExchangeMarket Cap£607.26M£14.98B£7.78B£2.57BDividend Yield1.17%2.61%4.57%5.31%P/E Ratio3,010.17345.99307.845,427.87Price / Sales2.2586.14212.1197,460.80Price / Cash4.1321.4028.9127.93Price / Book4.914.654.689.27Net Income£17.19M£223.64M£798.53M£5.89B7 Day Performance0.45%1.92%1.39%0.77%1 Month Performance4.23%2.60%2.46%44.86%1 Year Performance65.76%85.17%26.70%183.55% Cohort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHRTCohort3.1184 of 5 starsGBX 1,332+1.1%GBX 1,630+22.4%+61.9%£607.26M£270.04M3,010.171,243Positive NewsDividend CutCHGChemring Group1.3815 of 5 starsGBX 544.50+0.8%GBX 570+4.7%+53.4%£1.47B£521.30M3,446.202,600News CoverageDividend IncreaseBOEBoeingN/AN/AN/AN/A£1.32B£70.54B-30.77156,000Gap UpGECGeneral ElectricN/AN/AN/AN/A£1.14B£69.52B27.63125,000Positive NewsGap UpSNRSenior0.8611 of 5 starsGBX 189.60-1.0%GBX 202.50+6.8%+25.3%£783.81M£986.60M-10,193.556,679News CoverageAVONAvon ProtectionN/AGBX 1,944+0.8%N/A+69.4%£576.16M£296.60M9,213.27928Positive NewsDividend IncreaseHARLHarland & Wolff GroupN/AN/AN/AN/A£14.49M£86.91M-34.9081News CoverageVELVelocity Composites1.1337 of 5 starsGBX 20.59-3.3%GBX 60+191.4%-53.1%£11.26M£22.70M-1,502.92102Gap DownAEROStrat AeroN/AN/AN/AN/A£0.00N/A0.00N/AGap DownRRRolls-Royce Holdings plc3.6777 of 5 starsGBX 1,087-0.5%GBX 1,188.67+9.4%N/A£93.23B£18.13B39.6241,400Positive NewsHigh Trading VolumeBABAE Systems1.8095 of 5 starsGBX 1,792.50-0.2%GBX 1,964.25+9.6%+49.5%£55.49B£24.86B30.75156,000High Trading Volume Related Companies and Tools Related Companies Chemring Group Alternatives Boeing Alternatives General Electric Alternatives Senior Alternatives Avon Protection Alternatives Harland & Wolff Group Alternatives Velocity Composites Alternatives Strat Aero Alternatives Rolls-Royce Holdings plc Alternatives BAE Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CHRT) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cohort plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cohort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CHRT Stock Alerts